Takeda Pharmaceutical (TAK) Inventory Average (2018 - 2025)
Historic Inventory Average for Takeda Pharmaceutical (TAK) over the last 8 years, with Q4 2025 value amounting to $9.0 billion.
- Takeda Pharmaceutical's Inventory Average rose 1028.5% to $9.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 billion, marking a year-over-year increase of 1028.5%. This contributed to the annual value of $8.2 billion for FY2025, which is 439.55% up from last year.
- Latest data reveals that Takeda Pharmaceutical reported Inventory Average of $9.0 billion as of Q4 2025, which was up 1028.5% from $8.7 billion recorded in Q3 2025.
- Over the past 5 years, Takeda Pharmaceutical's Inventory Average peaked at $9.0 billion during Q4 2025, and registered a low of $6.7 billion during Q4 2022.
- Over the past 5 years, Takeda Pharmaceutical's median Inventory Average value was $7.8 billion (recorded in 2023), while the average stood at $7.7 billion.
- Per our database at Business Quant, Takeda Pharmaceutical's Inventory Average tumbled by 552.38% in 2022 and then skyrocketed by 1818.86% in 2023.
- Over the past 5 years, Takeda Pharmaceutical's Inventory Average (Quarter) stood at $7.1 billion in 2021, then dropped by 5.52% to $6.7 billion in 2022, then increased by 18.19% to $8.0 billion in 2023, then increased by 2.33% to $8.1 billion in 2024, then grew by 10.29% to $9.0 billion in 2025.
- Its Inventory Average was $9.0 billion in Q4 2025, compared to $8.7 billion in Q3 2025 and $8.3 billion in Q2 2025.